First Manhattan’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.58K | Hold |
26,000
| – | – | ﹤0.01% | 698 |
|
|
2025
Q1 | $8.11K | Hold |
26,000
| – | – | ﹤0.01% | 678 |
|
|
2024
Q4 | $24.3K | Hold |
26,000
| – | – | ﹤0.01% | 676 |
|
|
2024
Q3 | $30.7K | Hold |
26,000
| – | – | ﹤0.01% | 677 |
|
|
2024
Q2 | $20K | Hold |
26,000
| – | – | ﹤0.01% | 663 |
|
|
2024
Q1 | $79.3K | Hold |
26,000
| – | – | ﹤0.01% | 802 |
|
|
2023
Q4 | $83.7K | Hold |
26,000
| – | – | ﹤0.01% | 785 |
|
|
2023
Q3 | $99.8K | Hold |
26,000
| – | – | ﹤0.01% | 764 |
|
|
2023
Q2 | $85.3K | Hold |
26,000
| – | – | ﹤0.01% | 797 |
|
|
2023
Q1 | $67.1K | Hold |
26,000
| – | – | ﹤0.01% | 873 |
|
|
2022
Q4 | $48.4K | Hold |
26,000
| – | – | ﹤0.01% | 951 |
|
|
2022
Q3 | $47K | Hold |
26,000
| – | – | ﹤0.01% | 941 |
|
|
2022
Q2 | $55K | Hold |
26,000
| – | – | ﹤0.01% | 956 |
|
|
2022
Q1 | $81K | Buy |
26,000
+18,000
| +225% | +$56.1K | ﹤0.01% | 920 |
|
|
2021
Q4 | $25K | Sell |
8,000
-18,000
| -69% | -$56.3K | ﹤0.01% | 1130 |
|
|
2021
Q3 | $87K | Hold |
26,000
| – | – | ﹤0.01% | 889 |
|
|
2021
Q2 | $101K | Buy |
26,000
+8,000
| +44% | +$31.1K | ﹤0.01% | 861 |
|
|
2021
Q1 | $72K | Hold |
18,000
| – | – | ﹤0.01% | 885 |
|
|
2020
Q4 | $41K | Hold |
18,000
| – | – | ﹤0.01% | 938 |
|
|
2020
Q3 | $103K | Hold |
18,000
| – | – | ﹤0.01% | 770 |
|
|
2020
Q2 | $132K | Hold |
18,000
| – | – | ﹤0.01% | 718 |
|
|
2020
Q1 | $53K | Hold |
18,000
| – | – | ﹤0.01% | 836 |
|
|
2019
Q4 | $74K | Hold |
18,000
| – | – | ﹤0.01% | 842 |
|
|
2019
Q3 | $58K | Buy |
+18,000
| New | +$58K | ﹤0.01% | 888 |
|